Data / Form D filings / Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc.: Form D filing
Ascenta Therapeutics, Inc., a pharmaceuticals company in Malvern, PA, filed a Form D with the SEC in 2010. The latest, on February 5, 2010, reports $1.8 million sold of a $15 million offering to 12 investors.
Find out what Ascenta Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 LINDENWOOD DRIVE, SUITE 405, Malvern, PA, 19355
- Phone
- (610) 408-0301
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1483471
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2010 | New notice | $15,001,500 | $1,800,180 | $13,201,320 | 12 | Jan 25, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joel Sussman | Executive Officer, Director | |
| Eckard E. Weber | Director | |
| Norman Selby | Director | |
| Michael Powell | Executive Officer, Director | |
| Louis Bock | Director | |
| J. Mel Sorensen | Executive Officer, Director | |
| Andrew E. Senyei | Director | |
| Marc Lippman | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Feb 1, 2010 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ascenta Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.